Information Provided By: 
Fly News Breaks for July 19, 2017
ATHN
Jul 19, 2017 | 09:30 EDT
JPMorgan analyst Stephanie Davis raised her price target for athenahealth shares to $136 ahead of tomorrow's Q2 results. A "margin-focused turnaround" is the most likely outcome of the recent activist investment by Elliott, Davis tells investors in a research note. She believes athenahealth can achieve margin expansion of up to ten points over the coming years. The analyst adds, however, that margin upside is already priced in with shares up 35% since the activist stake was announced. She keeps a Neutral rating on athenahealth.
News For ATHN From the Last 2 Days
There are no results for your query ATHN
